SCHEMBL9588995

SCHEMBL9588995

CC(=O)OCCN1CCN(CCOC(C)=O)CC1.CCc1ccc(OC)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 2/20 0.47
DRD3 P35462 2/20 0.46
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
SIGMAR1 Q99720 3/20 0.46
EBP Q15125 2/20 0.46
TMEM97 Q5BJF2 1/20 0.46
LDHA P00338 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
SLC18A3 Q16572 1/20 0.45
DRD2 P14416 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9591281 0.99 SLC29A1 (0.51) SLC29A1SMN1; SMN2LMNADRD3KMT2A
SCHEMBL9588640 0.81 SLC29A1 (0.48) SLC29A1SMN1; SMN2LMNADRD3KMT2A
Hydrochloric Acid SCHEMBL9589396 0.80 SLC29A1 (0.47) SLC29A1SMN1; SMN2LMNADRD3KMT2A
SCHEMBL9588553 0.79 SLC18A3 (0.49) DRD3SLC18A3DRD2
SCHEMBL9590109 0.79 DRD3 (0.59) LMNADRD3KMT2AMEN1SIGMAR1
Ethylbenzene SCHEMBL9590427 0.78 SLC18A3 (0.62) SMN1; SMN2KMT2AMEN1KDM4EGAA
Hydrochloric Acid SCHEMBL9589481 0.77 DRD3 (0.58) SMN1; SMN2LMNADRD3KMT2AMEN1
Hydrochloric Acid SCHEMBL9589159 0.77 SLC18A3 (0.48) DRD3SLC18A3DRD2
Ethylbenzene SCHEMBL9588725 0.77 SLC18A3 (0.60) KMT2AMEN1KDM4EGAASLC18A3
SCHEMBL27806086 0.76 APP (0.55) KDM4ELDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US claimed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP claimed
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP disclosed